MIAMI

迈阿密

,

，

April 6, 2026

2026年4月6日

/PRNewswire/ -- Global law firm

/PRNewswire/ -- 全球律师事务所

Greenberg Traurig, P.A.

格林伯格·特劳里格律师事务所

advised Israel-based Entera Bio Ltd. (Nasdaq:

建议以色列的Entera Bio Ltd.（纳斯达克：

ENTX

ENTX

), a clinical-stage biotechnology company focused on the development of oral peptide and protein replacement therapies, in a $10 million private placement led by funds affiliated with private investment firm BVF Partners L.P.

），这是一家临床阶段的生物技术公司，专注于口服肽和蛋白质替代疗法的开发，在由私人投资公司BVF Partners L.P.旗下基金领投的1000万美元私募融资中。

Under the terms of the transaction, which closed April 2, Entera issued and sold an aggregate of 7,827,789 units at a purchase price of $1.2775 per unit, according to the

根据协议条款，该交易于4月2日完成，Entera发行并出售了总计7,827,789个单位，每个单位的购买价格为1.2775美元， according to the

company's press release

公司新闻稿

. Each unit consists of one ordinary share of Entera, or a pre-funded warrant in lieu thereof, and a five-year warrant to purchase one and a half ordinary shares at an exercise price of $1.24 per share, representing an 11.7% premium to the company's recent closing market price.

每个单位包括一股Entera普通股或预融资认股权证，以及一份五年期认股权证，可按每股1.24美元的价格购买一股半普通股，较公司最近的收盘价溢价11.7%。

Gross proceeds from the private placement were approximately $10 million, before deducting offering expenses. If all warrants issued in the financing are exercised for cash, Entera could receive additional proceeds of approximately $14.5 million, resulting in total potential proceeds of approximately $24.5 million..

私募配售的总收益约为 1000 万美元，尚未扣除发行费用。如果融资中发行的所有认股权证均通过现金行权，Entera 可能会额外获得约 1450 万美元的收益，潜在总收益约为 2450 万美元。

The Greenberg Traurig team advising Entera was led by

格林伯格·特劳里格律师事务所为Entera提供咨询的团队由

Drew M. Altman

德鲁·M.奥尔特曼

, co-chair of the

，联合主席

Miami Corporate Practice

迈阿密公司业务实践

, with Corporate Shareholder

，与企业股东

Sami B. Ghneim

萨米·B·格尼姆

and Law Clerk Elizabeth Ferrie supporting.

以及法律助理伊丽莎白·费里提供支持。

Entera disclosed that it intends to use the net proceeds from the private placement, together with its existing cash and cash equivalents, to support activities related to the initiation of its Phase 3 registrational study of EB613 in postmenopausal women with osteoporosis, as well as for working capital and general corporate purposes..

Entera 披露，其计划将此次私募所得的净收益与其现有的现金及现金等价物一起用于支持与启动针对绝经后骨质疏松症女性的 EB613 第三期注册研究相关的活动，以及用于营运资金和一般公司用途。

About Greenberg Traurig:

关于格林伯格·特劳里格：

Greenberg Traurig, LLP has more than 3,100 lawyers across 51 locations in the United States, Europe, the Middle East, Latin America, and Asia. The firm's broad geographic and practice range enables the delivery of innovative and strategic legal services across borders and industries. Recognized as a 2025 BTI 'Best of the Best Recommended Law Firm' by general counsel for trust and relationship management, Greenberg Traurig is consistently ranked among the top firms on the Am Law Global 100, NLJ 500, and Law360 400.

格林伯格·特劳里格律师事务所（Greenberg Traurig, LLP）在美国、欧洲、中东、拉丁美洲和亚洲的51个地点拥有3100多名律师。该事务所广泛的地理覆盖范围和业务领域使其能够跨越国界和行业提供创新且战略性的法律服务。格林伯格·特劳里格因其信任与关系管理能力被总法律顾问评为2025年BTI“最佳推荐律师事务所”之一，并持续在《美国律师》全球100强、《国家法律期刊》500强以及《Law360》400强中名列前茅。

Greenberg Traurig is also known for its philanthropic giving, culture, innovation, and pro bono work. Web: .

格林伯格·特劳里格也因其慈善捐赠、文化、创新和无偿工作而闻名。网站：。

www.gtlaw.com

www.gtlaw.com

.

。

SOURCE Greenberg Traurig, LLP

来源：Greenberg Traurig, LLP律师事务所

21

21

%

%

more press release views with

更多新闻稿浏览量与

Request a Demo

请求演示